Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs using drug delivery technologies. The company has three products, all of which are approved by the FDA: Lipofen® for the treatment of high cholesterol; ConZip®/Durela® for the treatment of moderate to moderately severe pain; and Cip-Isotretinoin for the treatment of severe acne. For further information, visit the company’s Web site at www.cipherpharma.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: